Back to News
Market Impact: 0.2
Nuwellis Submits FDA Application To Expand Aquadex Use In Pediatric Patients
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct Launches
Nuwellis announced that it submitted a 510(k) premarket notification to the FDA seeking to expand the indication for its Aquadex SmartFlow System. The available article text is truncated before specifying the proposed indication or any FDA decision, so the scope and timing of a potential expansion are not stated.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.10
Ticker Sentiment
NUWE0.45
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- South Korea’s KOSPI halts trade after 8% wipeout on AI losses
- U.S. stock futures rise after AI rout batters Wall St; payrolls data in focus
- ’Our phones are exploding’: Goldman Sachs dissects historic Wall Street crash